Trem2 acts as a non‐classical receptor of interleukin‐4 to promote diabetic wound healing
Trem2 wirkt als nicht-klassischer Rezeptor von Interleukin-4 und fördert die Wundheilung bei Diabetes
Clinical and Translational Medicine · 2024-10 · 14 (10)
DOI: 10.1002/ctm2.70026 ↗Auf einen Blick
Bei diabetischen Mausmodellen war Trem2 nach Wundinduktion in Makrophagen erhöht. Ein Makrophagen-spezifischer Trem2-Knockout verschlechterte Entzündung und Wundheilung.
Fragestellung
Welche Rolle spielt Trem2 bei der diabetischen Wundheilung und über welche Mechanismen wirkt es?
Methode
Experimentelle Tierstudie mit diabetischen Modellmäusen; Analyse von Trem2 in Makrophagen, Makrophagen-spezifischem Trem2-Knockout, Zellkultur und in vivo-Intervention mit löslichem Trem2.
Ergebnisse
T2-cKO-Mäuse zeigten stärkere Entzündungsreaktionen, langsameren Wundschluss, geringere Neovaskularisation und weniger Kollagenablagerung. IL-4 band direkt an Trem2 und hemmte MAPK/AP-1. Lösliches Trem2 reduzierte Entzündung und förderte die Wundheilung.
Schlussfolgerung der Autor:innen
Die Analysen liefern neue Einblicke in IL-4/Trem2-Signale als Vermittler des Myeloid-Zell-Fibroblasten-Kontakts und deuten auf Trem2 als möglichen therapeutischen Zielort zur Verbesserung der diabetischen Wundheilung hin.
Kernaussagen
- Trem2 war nach Wundinduktion in Makrophagen erhöht
- Trem2-Knockout verschlechterte Entzündung und Wundheilung
- Lösliches Trem2 förderte in vivo die Wundheilung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 30.09.2024. Verfasst von Xinlin Zhu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Shanghai Key Laboratory of Medical Mycology; The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), …. Hauptthemen laut MEDLINE: Receptors, Immunologic, Wound Healing, Membrane Glycoproteins, Interleukin-4. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Project of the Ministry of Science and Technology, Shanghai Science and Technology Committee.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
The immunoglobulin superfamily protein Trem2 (triggering receptor expressed on myeloid cells 2) is primarily expressed on myeloid cells where it functions to regulate macrophage‐related immune response induction. While macrophages are essential mediators of diabetic wound healing, the specific regulatory role that Trem2 plays in this setting remains to be established.
Objective
This study was developed to explore the potential importance of Trem2 signalling in diabetic wound healing and to clarify the underlying mechanisms through which it functions. Methods and results Following wound induction, diabetic model mice exhibited pronounced upregulation of Trem2 expression, which was primarily evident in macrophages. No cutaneous defects were evident in mice bearing a macrophage‐specific knockout of Trem2 (T2‐cKO), but they induced more pronounced inflammatory responses and failed to effectively repair cutaneous wounds, with lower levels of neovascularization, slower rates of wound closure, decreased collagen deposition following wounding. Mechanistically, we showed that interleukin (IL)‐4 binds directly to Trem2, inactivating MAPK/AP‐1 signalling to suppress the expression of inflammatory and chemoattractant factors. Co‐culture of fibroblasts and macrophages showed that macrophages from T2‐cKO mice suppressed the in vitro activation and proliferation of dermal fibroblasts through upregulation of leukaemia inhibitory factor (Lif). Injecting soluble Trem2 in vivo was also sufficient to significantly curtail inflammatory responses and to promote diabetic wound healing.
Conclusions
These analyses offer novel insight into the role of IL‐4/Trem2 signalling as a mediator of myeloid cell‐fibroblast crosstalk that may represent a viable therapeutic target for efforts to enhance diabetic wound healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Shanghai Key Laboratory of Medical Mycology; The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), Shanghai Changzheng Hospital, Naval Medical University, Shanghai, Chin…
- Department of Vascular Surgery, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
- Department of Laboratory Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
ORCID-Profile: Qian Wu, Weihua Pan
Förderung
- National Natural Science Foundation of China
- Project of the Ministry of Science and Technology
- Shanghai Science and Technology Committee
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhu, X., Zhang, C., Jiang, W., Zeng, Z., Zhang, K., Du, M., Chen, J., Wu, Q., Liao, W., Chen, Y., Fang, W., & Pan, W. (2024). Trem2 acts as a non‐classical receptor of interleukin‐4 to promote diabetic wound healing. Clinical and Translational Medicine, 14(10). https://doi.org/10.1002/ctm2.70026
Vancouver
Zhu X, Zhang C, Jiang W, Zeng Z, Zhang K, Du M, et al. Trem2 acts as a non‐classical receptor of interleukin‐4 to promote diabetic wound healing. Clinical and Translational Medicine. 2024;14(10). doi:10.1002/ctm2.70026
BibTeX
@article{Zhu2024,
author = {Zhu, Xinlin and Zhang, Chao and Jiang, Weiwei and Zeng, Zhaoxiang and Zhang, Keming and Du, Mingwei and Chen, Juan and Wu, Qian and Liao, Wanqing and Chen, Youming and Fang, Wenjie and Pan, Weihua},
title = {Trem2 acts as a non‐classical receptor of interleukin‐4 to promote diabetic wound healing},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {10},
doi = {10.1002/ctm2.70026}
}
EUVIMED